SUN Pharmaceutical Industries Limited Dolutegravir Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Dolutegravir Export Records India — #7 Exporter, 69 Shipments, $3.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Dolutegravir

India Pharmaceutical Trade Intelligence

$4.2B104 Suppliers145 CountriesHS 30049099

ExportsIndia → BOTSWANA75.3%India → TANZANIA6.1%

ImportsCANADA → India$1.0M UNITED STATES → India$970.9K

#1 Buyer: AFRICURE PHARMACEUTICALS

SUN Pharmaceutical Industries Limited — Dolutegravir Exporter #7 | $3.5M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Dolutegravir Exporter Profile

Indian Pharmaceutical Exporter · #7 for Dolutegravir · $3.5M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #7 Indian exporter of Dolutegravir with $3.5M in export value and 69 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.1% market share in Dolutegravir exports across 14 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Dolutegravir Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Dolutegravir export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Dolutegravir?

Country	Value	Shipments	Share
PHILIPPINES	$850.0K	17	28.2%
SOUTH AFRICA	$831.8K	20	27.6%
CAMEROON	$250.0K	5	8.3%
MOZAMBIQUE	$250.0K	5	8.3%

Who Are the Top Buyers of Dolutegravir from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
SUN PHARMA PHILIPPINES INC	PHILIPPINES	$850.0K	17
RANBAXY PHARMACEUTICALS PTY LTD.,	SOUTH AFRICA	$646.4K	15
PROGRAMME NATIONAL DE LUTTE	COTE D IVOIRE	$108.9K	3
UAB VILNIAUS TRANZITAS	LITHUANIA	$100.0K	2
PRIMATURE UNITE DE GESTION DES	TOGO	$100.0K	2
CENAME ON BEHALF OF THE MINISTRY	CAMEROON	$100.0K	2
MINISTERIO DA SAUDE CENTRAL DE	MOZAMBIQUE	$100.0K	2
RANBAXY PHARMACEUTICALS PTY LIMITED	SOUTH AFRICA	$100.0K	2
CENAME	CAMEROON	$100.0K	2
A. FERREIRA GOMES LDA, VAT - PT5000	ANGOLA	$68.5K	7

SUN Pharmaceutical Industries Limited supplies Dolutegravir to 28 buyers globally. The largest buyer is SUN PHARMA PHILIPPINES INC (PHILIPPINES), followed by RANBAXY PHARMACEUTICALS PTY LTD., (SOUTH AFRICA) and PROGRAMME NATIONAL DE LUTTE (COTE D IVOIRE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Dolutegravir Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
DOLUTEGRAVIR TABS 50MG EACH.TAB CONT.DOLUTEGRAVIR 50MG,PACK:30s Bottle,Batch: PTG1267C MFD: 07.03.2025 EXP : 29.02.2028	$800.0K	16
DLT (DOLUTEGRAVIR, LAMIVUDINE AND TENOFO	$200.0K	4
VIDOTEG TAB 50MG EACH TAB CONTAINS DOLUTEGRAVIR 50MG PACK :30 SP	$150.0K	3
DOLUTEGRAVIR TAB 50MG EACH TAB CONTAINS	$123.1K	5
VIDOTEG TABS 50MG EACH TAB CONTAINS DOLUTEGRAVIR 50MG PACK : SP 30s Bottle	$118.4K	3
DOLUTEGRAVIR TAB 50MG 30BTL BY (TO) B/NO	$100.0K	2
TELATRI TAB 50/300/300MG EACH FILM COATED TAB CONTAINS: DOLUTEGRAVIR 50MG LAMIVUDINE USP 300MG TENOFOVIR DISOPROXIL FU	$100.0K	2
TELATRI TAB 50/300/300MG EACH FILM COATED TAB CONTAINS: DOLUTEGRAVIR 50MG, LAMIVUDINE USP 300MG, TENOFOVIR DISOPROXIL FU	$100.0K	2
VIDOTEG TAB 50MG EACH TAB CONTAINS DOLUTEGRAVIR 50MG PACK : 30S BOTTLENOS	$78.0K	3
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABS 50/300/300MG EACH TAB CONTAINS DOLUTEGRAVIR 50MG,****	$68.5K	7

SUN Pharmaceutical Industries Limited exports 36 distinct Dolutegravir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOLUTEGRAVIR TABS 50MG EACH.TAB CONT.DOLUTEGRAVIR 50MG,PACK: with 16 shipments worth $800.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Dolutegravir Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	MACLEODS PHARMACEUTICALS LIMITED	$6.7M	134	30	$50.0K
11	MYLAN LABORATORIES LIMITED	$5.5M	110	20	$50.0K
7	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$3.5M	69	14	$50.0K
6	APL HEALTHCARE LIMITED	$2.5M	51	9	$50.0K
5	STRIDES PHARMA SCIENCE LIMITED	$1.9M	39	12	$50.0K

SUN Pharmaceutical Industries Limited ranks #7 among 104 Indian Dolutegravir exporters. Average shipment value of $50.0K compared to the market average of $1.4M. The closest competitors by value are MACLEODS PHARMACEUTICALS LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Dolutegravir Exports?

Port	Shipments	% Share
SAHAR AIR	610	18.3%
NHAVA SHEVA SEA (INNSA1)	465	14.0%
JNPT/ NHAVA SHEVA SEA	316	9.5%
SAHAR AIR CARGO ACC (INBOM4)	284	8.5%
JNPT	180	5.4%
HYDERABAD ACC (INHYD4)	164	4.9%
HYDERABAD AIR	147	4.4%
DELHI AIR	137	4.1%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Dolutegravir Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Dolutegravir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 73 individual customs records matching SUN Pharmaceutical Industries Limited exporting Dolutegravir, covering 36 formulations to 15 countries via 28 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 592+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Dolutegravir

Dolutegravir

SUN Pharmaceutical Industries Limited — Dolutegravir Exporter Profile

SUN Pharmaceutical Industries Limited — Dolutegravir Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Dolutegravir?

Who Are the Top Buyers of Dolutegravir from SUN Pharmaceutical Industries Limited?

What Is India's Total Dolutegravir Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Dolutegravir Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Dolutegravir Exporters?

What Dolutegravir Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Dolutegravir to Key Markets

South Africa — SAHPRA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Dolutegravir Exporters?

Which Indian Ports Ship Dolutegravir Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Dolutegravir Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Dolutegravir Export Data from SUN Pharmaceutical Industries Limited

Dolutegravir Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source